Tuesday, October 15, 2019

Is Green Tea a Fad or a Real Health Boost?

›
In continuation of my updates on Green tea Green tea is a popular health trend, with many people sipping in hopes of deriving benefi...
Saturday, October 12, 2019

Coffee Might Be Your Go-to Brew for Weight Loss

›
In continuation of my update on coffee Could America's favorite morning drink also help fight one of its biggest health issues, ...
Friday, October 11, 2019

AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients

›
In continuation of my update on  Venclexta (venetoclax) AbbVie a research-based global biopharmaceutical  company,  announced th...
Thursday, October 10, 2019

FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes

›
In continuation of my update on Victoza (liraglutide) The U.S. Food and Drug Administration   approved Victoza (liraglutide) injection...
Wednesday, October 9, 2019

FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of CF in Children Ages 6-11 Years with Certain Mutations in the CFTR Gene

›
In continuation of my update on tezacafto     Tezacaftor                                                                           ...
Tuesday, October 8, 2019

FDA Approves Gattex (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)

›
In continuation of my update on  Teduglutide Takeda Pharmaceuticals, U.S.A., Inc. (“Takeda”), announced  that the U.S. Food and Dr...
Monday, October 7, 2019

FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients

›
     In continuation of my update on  Dalteparin U.S. Food and Drug Administration,  approved   Fragmin   (dalteparin sodium) ...
Saturday, October 5, 2019

FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma

›
In continuation of my update on   lenalidomide Celgene Corporation,  announced the U.S. Food and Drug Administration (FDA) approve...
Friday, October 4, 2019

FDA Approves Sorilux for Adolescent Plaque Psoriasis

›
In continuation of my update on Sorilux(calcipotriene)     Mayne Pharma Group Limited, announced that the US Food and Drug Admin...